Buying AOD-9604 5mg for laboratory research involves more than finding a supplier with a competitive price. UK buyers need to establish what material is being offered, whether its identity and stated quantity are supported by appropriate documentation, and whether the product format is suitable for their intended analytical work.
Two suppliers may advertise AOD-9604 5mg while providing very different levels of product information. One listing may identify the peptide sequence, batch number and available analytical methods. Another may display only the compound name, strength and a general purity percentage.
Those differences matter when research laboratories need traceable materials and reproducible analytical records.
This guide explains how to compare AOD-9604 5mg UK suppliers, assess certificates of analysis, distinguish product formats and identify documentation gaps before placing an order.
What Is AOD-9604 5mg?
AOD-9604 is a synthetic peptide derived from the C-terminal region of human growth hormone. It is commonly described as a modified fragment corresponding to amino acids 176–191 of human growth hormone.
The compound has been studied in relation to lipid metabolism and metabolic signalling, although laboratory research findings should not be interpreted as established clinical benefits.
The designation 5mg generally indicates the stated quantity of AOD-9604 in a product unit, such as a research vial.
It does not independently establish the actual peptide content, chemical purity, concentration of a prepared solution or suitability for a particular analytical method.
What should the product name tell buyers?
A useful supplier listing should identify the material sufficiently for a laboratory to distinguish it from other growth hormone fragments.
Relevant information may include:
- Compound designation: AOD-9604
- Stated peptide quantity: 5mg
- Physical format: lyophilised powder or prepared research solution
- Molecular or sequence identification
- Batch or lot number
- Available analytical documentation
- Storage and handling information appropriate to the format
Where a supplier uses an alternative peptide designation, the laboratory should confirm that it refers to the intended chemical entity rather than assuming equivalence.
How to Compare AOD-9604 Research Peptide Suppliers in the UK
The most useful supplier comparison begins with documentation rather than marketing language.
A lower price may be attractive, but it offers limited value if the laboratory cannot establish what material will arrive or how the supplier supports its specifications.
1. Check the exact product identity
The supplier should clearly identify the compound being sold.
AOD-9604 should not be treated as interchangeable with full-length human growth hormone or other growth hormone-derived peptides.
Differences in peptide sequence and modification can affect molecular identity and analytical behaviour.
Where sequence information is supplied, laboratories can compare it with the intended research material and the relevant analytical records.
2. Verify the stated 5mg quantity
A product labelled AOD-9604 5mg should have a clearly defined quantity claim.
For a powder vial, the laboratory should establish whether the stated amount refers to peptide content, total formulated material or another defined quantity.
For a prepared solution, both the total stated peptide quantity and solution volume are relevant.
A 5mg label alone does not establish concentration.
3. Ask about batch-specific documentation
A supplier’s certificate of analysis should identify the material and batch to which its results apply.
Generic example certificates may help buyers understand the supplier’s testing format, but they should not be treated as evidence for an unrelated batch.
Before ordering, laboratories should establish whether batch-specific analytical information is available and how it can be matched to the delivered material.
4. Examine the testing methods
Different analytical methods answer different questions.
Chromatographic testing may provide information about separated components within a sample, while mass spectrometry may support molecular-mass or identity assessment.
Neither method automatically proves every aspect of material quality.
Buyers should consider whether the analytical methods are appropriate for the claims being made.
5. Compare delivery and storage information
The supplier should explain the intended shipping arrangements and provide storage guidance supported by the relevant material information.
Laboratories should not assume that all peptide powders and prepared solutions have identical stability characteristics.
AOD-9604 Supplier Comparison Checklist
| Evaluation criterion | What buyers should check | Potential concern |
|---|---|---|
| Product identity | Defined AOD-9604 designation and supporting identifiers | Ambiguous compound name |
| Strength | Clear explanation of the stated 5mg quantity | Unclear content basis |
| Format | Powder or solution identified | Format not disclosed |
| Batch information | Traceable batch or lot identifier | No batch reference |
| COA | Document applicable to the supplied batch | Generic certificate presented as batch evidence |
| Purity evidence | Method, result and interpretation available | Percentage without testing context |
| Quantity evidence | Suitable assay information where required | Purity percentage used as proof of content |
| Packaging | Container and label details | Missing or inconsistent identification |
| Storage | Format-appropriate instructions | Unsupported universal shelf-life claims |
| Delivery | Clear dispatch and shipping information | Unexplained handling arrangements |
A supplier does not necessarily need to publish every analytical document openly on its product page. However, buyers should establish what evidence is available before relying on the stated specifications.
AOD-9604 Powder vs Liquid: Which Format Should UK Laboratories Consider?
AOD-9604 may be offered as a lyophilised powder or a prepared research solution.
These formats should be evaluated separately because their specifications and handling considerations differ.
Lyophilised AOD-9604 powder
Lyophilised material is produced through a freeze-drying process intended to remove water under controlled conditions.
For laboratory procurement, relevant considerations include the stated peptide content, excipients where applicable, container integrity and storage information.
The appearance of a freeze-dried cake does not independently demonstrate peptide identity or purity.
Prepared AOD-9604 solution
A prepared solution introduces additional formulation characteristics.
Buyers may need information about solution volume, concentration, solvent or vehicle composition, pH and the basis for any stated stability period.
A clear-looking solution does not establish chemical purity, microbiological quality or absence of degradation.
Powder and liquid comparison
| Specification | Lyophilised powder | Prepared solution |
|---|---|---|
| Stated peptide amount | Usually expressed per vial | May be expressed per container and concentration |
| Additional composition | Excipients, where present | Solvent, buffer and other formulation components |
| Analytical considerations | Identity, content and impurities | Identity, concentration, impurities and formulation compatibility |
| Storage assessment | Powder-specific stability evidence | Solution-specific stability evidence |
| Supplier questions | Content basis and packaging | Concentration, vehicle and validated handling information |
Neither format should automatically be described as more stable, more accurate or more suitable without supporting evidence relevant to the particular product.
How to Read an AOD-9604 Certificate of Analysis
A certificate of analysis can help laboratories assess the evidence supporting a supplier’s product specifications.
However, the value of a COA depends on the methods used, the information reported and whether the document applies to the material being purchased.
Check the document identifiers
The compound designation, batch number and relevant product details should be consistent with the supplier’s listing and delivered label.
A mismatch requires clarification.
Understand what HPLC purity means
High-performance liquid chromatography separates sample components according to their behaviour under defined analytical conditions.
A chromatographic area percentage may describe the proportion of detected signal associated with a particular peak.
It should not automatically be interpreted as the absolute mass fraction of the intended peptide.
The result depends on the analytical method, detection conditions and components included in the measurement.
Understand what mass spectrometry establishes
Mass spectrometry can provide evidence about molecular mass and, depending on the analytical approach, structural characteristics.
A result consistent with the expected mass can support an identity assessment.
However, mass agreement alone may not distinguish every possible structural isomer or establish chemical purity.
Purity is not the same as peptide content
This distinction is particularly important for AOD-9604 5mg products.
A material described as 99% chromatographically pure is not necessarily demonstrated to contain 4.95mg of the intended peptide in a vial labelled 5mg.
Determining actual content requires an appropriate quantitative approach and consideration of the material’s composition.
What Should an AOD-9604 Product Listing Include?
A useful product page should answer the most important procurement questions without requiring buyers to infer missing details.
At minimum, laboratories should look for a clear product name, strength, format, supporting identifiers and an explanation of available documentation.
For example, a listing might identify AOD-9604 5mg as a lyophilised research peptide and provide a route for requesting the relevant batch records.
Peptide Lab Direct UK maintains a research compound catalogue that UK buyers can consult when comparing available materials and stated product formats.
Buyers should independently verify the exact product specifications and applicable documentation before procurement.
How to Evaluate AOD-9604 Pricing
The advertised vial price is only one part of the purchasing decision.
Laboratories should compare the complete offer.
This may include:
- Stated peptide quantity
- Whether the material is powder or solution
- Available batch documentation
- Shipping charges
- Applicable taxes or import costs
- Minimum order requirements
- Packaging and delivery arrangements
Example: Comparing three hypothetical suppliers
The following examples are illustrative, not real supplier assessments.
| Criterion | Supplier A | Supplier B | Supplier C |
|---|---|---|---|
| Advertised product | AOD-9604 5mg | AOD-9604 5mg | AOD-9604 5mg |
| Format | Powder | Powder | Solution |
| Batch identifier | Available | Not stated | Available |
| Analytical document | Batch-linked report | Generic example | Batch-linked report |
| Content basis | Explained | Unclear | Concentration stated |
| Storage information | Product-specific | Generic | Product-specific |
Supplier A and Supplier C provide more information for an initial evaluation.
Supplier B requires clarification before the laboratory can establish whether its product meets the intended procurement requirements.
This does not establish that any of the hypothetical suppliers has acceptable material quality. The supporting evidence would still need to be reviewed.
What Should UK Laboratories Ask Before Ordering AOD-9604?
A short, structured enquiry can reveal whether a supplier understands the documentation requirements of laboratory buyers.
Suggested supplier enquiry
Subject: AOD-9604 5mg Research Material — Specification and Batch Documentation Request
Hello,
We are reviewing AOD-9604 5mg for laboratory research procurement.
Could you confirm the following details?
- The exact compound designation and available molecular identifiers.
- Whether the product is supplied as lyophilised powder or a prepared solution.
- What the stated 5mg quantity represents.
- Whether a certificate of analysis is available for the batch being supplied.
- Which analytical methods support the identity and purity claims.
- Whether quantitative peptide-content information is available.
- The recommended storage conditions and supporting product information.
- The applicable delivery arrangements for UK laboratory orders.
Please also confirm how the batch number on the delivered container will match the supporting documentation.
Thank you.
This enquiry helps establish whether the supplier can provide information suitable for a laboratory’s purchasing records.
Common Mistakes When Buying AOD-9604 5mg
Choosing a supplier solely on price
The lowest advertised price does not necessarily represent the most suitable procurement option.
Incomplete documentation can create additional verification work or make the material unsuitable for the intended analytical study.
Assuming all 5mg products are equivalent
Two products with the same stated strength may differ in format, composition, supporting documentation and analytical characteristics.
Treating a purity percentage as complete quality evidence
A single purity figure cannot establish identity, quantity, sterility, endotoxin status or stability.
These characteristics require separate evidence where relevant.
Ignoring the batch number
Without batch traceability, it may be difficult to connect the delivered material to the correct analytical records.
Assuming research materials are authorised medicines
AOD-9604 sold as a laboratory research material should not be represented as a licensed medicinal product.
Research-only supply does not establish suitability for human administration.
AOD-9604 5mg UK: Final Procurement Decision Framework
Before approving a purchase, laboratories can place a supplier’s offer into one of three categories.
| Decision | Evidence position | Suggested action |
|---|---|---|
| Suitable for further procurement review | Required specifications and documentation are available and consistent | Continue through the laboratory’s purchasing procedure |
| Clarification required | Some information is missing or ambiguous | Request written clarification |
| Insufficient evidence | Critical identity, quantity or traceability information cannot be established | Do not approve until the deficiency is resolved |
This approach avoids treating every missing detail as equally serious.
For example, an unanswered question about packaging dimensions may be straightforward to resolve. An unresolved mismatch between the compound identity on a label and its analytical report is more significant.
Frequently Asked Questions
Where can UK laboratories buy AOD-9604 5mg?
Laboratories can evaluate specialist research-material suppliers offering AOD-9604, subject to verifying product availability, identity, documentation and applicable purchasing requirements.
What does AOD-9604 5mg mean?
It generally indicates a stated quantity of 5mg of AOD-9604 per product unit. The exact content basis should be confirmed with the supplier.
Is an HPLC purity result enough to verify AOD-9604?
No. HPLC purity information should be interpreted alongside suitable identity and, where necessary, quantitative testing.
Is AOD-9604 powder better than liquid?
Neither format is universally better. Suitability depends on the intended laboratory work and the specific formulation and stability evidence.
Should an AOD-9604 COA match the delivered batch?
Yes. The documentation relied upon should be applicable to the material and batch supplied.
Can AOD-9604 research material be used for human administration?
A laboratory research designation does not establish medicinal authorisation, clinical suitability or permission for human administration.
Conclusion
Choosing an AOD-9604 5mg supplier in the UK requires a clear understanding of what is being purchased.
The strongest procurement decisions are based on consistent product identification, meaningful analytical documentation, batch traceability and specifications appropriate to the intended research.
Laboratories should distinguish between what a supplier advertises and what its supporting evidence actually establishes.
For buyers reviewing research-material options, Peptide Lab Direct UK’s quality and COA information can be included in the documentation review, with batch-specific evidence requested where relevant.
The objective is not simply to find an AOD-9604 5mg listing. It is to identify a research material whose stated characteristics can be evaluated before the laboratory commits to purchasing it.
Research-use notice: This article concerns laboratory procurement and analytical evaluation. It does not provide clinical guidance or establish that AOD-9604 is authorised for human use.
Scientific References
- Heffernan MA, et al. The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism. Endocrinology. 2001. https://pubmed.ncbi.nlm.nih.gov/?term=AOD9604+lipid+metabolism+Heffernan
- International Council for Harmonisation. ICH Q2(R2): Validation of Analytical Procedures. https://www.ich.org/page/quality-guidelines
- International Council for Harmonisation. ICH Q14: Analytical Procedure Development. https://www.ich.org/page/quality-guidelines
- International Organization for Standardization. ISO/IEC 17025: General Requirements for the Competence of Testing and Calibration Laboratories. https://www.iso.org/standard/66912.html